Findings from the study confirm the derangement of fat metabolism in the ovariectomized rats and showed that incretin‐based therapy and exercise synergistically improved liver fat metabolism, achieved significant beneficial metabolic effects and offer full protection against NAFLD. The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.